The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Open accessAbstract
Aging is a physiological decline in both structural homeostasis and functional integrity, progressively affecting organismal health. A major hallmark of aging is the accumulation of senescent cells, which have entered a state of irreversible cell cycle arrest after experiencing inherent or environmental stresses. Although cellular senescence is essential in several physiological events, it plays a detrimental role in a large array of age‐related pathologies. Recent biomedical advances in specifically targeting senescent cells to improve healthy aging, or alternatively, postpone natural aging and age‐related diseases, a strategy termed senotherapy, have attracted substantial interest in both scientific and medical communities. Challenges for aging research are highlighted and potential avenues that can be leveraged for therapeutic interventions to control aging and age‐related disorders in the current era of precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The canonical hallmarks of aging, its accompanying chronic diseases and potential interventions. Aging is characterized by a set of typical hallmarks, including genomic instability, epigenetic alterations, mitochondrial dysfunction, loss of proteostasis, telomere attrition, deregulated nutrient sensing, stem cell exhaustion, and cellular senescence. During natural aging, the incidence of age‐related pathologies increases in a progressive manner, most of which implicate cellular senescence. Therapeutic avenues involving genetic, dietary, or pharmacologic approaches have emerged as potent intervention strategies to prevent or ameliorate aging symptoms, although with different mechanisms. Given that the aged population in a global range is drastically increasing and that aging outstands as the greatest risk factor for the vast majority of chronic diseases responsible for both morbidity and mortality, it is critical, urgent and sagacious to expand geroscience aimed at improving human healthspan. Note, the course of organismal aging is indeed accompanied by various natural activities such as revolution of planets in the universal setting, day and night (exemplified as symbols at the corners of the circle). Part of the figure (mainly the circle) is adapted with permission.[ 164 ] Copyright year 2020, CellPress.](https://figures.cochat.ai/paper-figures/664ca0a633c647179e3ccb12584b9894/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-1.jpg)
![Figure 2 Emerging strategies that showed efficacy in targeting cellular senescence. At late or advanced stages of life, senescent cells progressively accumulate in multiple tissue types and substantially promote the development of multiple age‐related diseases. Increasing lines of studies suggest that targeting specific fundamental mechanisms of aging may be more effective than treating each chronic pathology individually to restrain the impacts of aging on healthspan and lifespan. Pilot trials have been initiated to therapeutically target cellular senescence, such as A) selectively removing senescent cells via induction of their death (senolytic treatment), and B) engagement of the immune surveillance (senescence‐directed immunotherapy), with the potential of each strategy in depleting senescent cells from tissue microenvironment demonstrated by recent investigations. In each mechanistic illustration, yellow arrows mean stimulating or promotive actions, while red arrows represent suppressive or counteractive functions. A) Agents within yellow rectangles are example senolytics. B) Scissors represent shedding of NKG2D ligands by MMPs secreted by senescent cells, especially those induced by oncogene activation. (A) adapted with permission.[ 164 ] Copyright year 2020, CellPress. We stated “Figure (A) adapted with permission [164]. Copyright year 2020, CellPress.” Please refer to Page 33 (Figure legend, Figure 2).](https://figures.cochat.ai/paper-figures/13699244bcbb4d1e845514c41625c336/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-2.jpg)
![Figure 3 A hypothetic model to illustrate senotherapy‐mediated healthy aging. The first stage of the survival curve refers to the pre‐mortality plateau phase (PPP), during which ≈10% of the overall population is lost over a relatively long period. Alternatively referred to as a healthy lifespan, the PPP covers three sub‐stages, including an adolescent period when the body actively develops, a young adult period when the individual is physiologically mature, and a middle‐aged period when the mortality rate begins to increase. During the overall PPP span, 90% of the population remains alive, after which the mortality rate significantly arises and the population declines rapidly, a period constituting the late‐aged phase. However, in the case of senotherapy which theoretically comprises multiple waves of medications with senolytics administered in an intermittent or metronomic manner, the lifespan can be remarkably extended. Senotherapy can eliminate senescent cells, promote tissue repair, improve organ regeneration, and ameliorate multiple age‐related pathologies, thus providing a prominent avenue for a healthier aging of human populations.[ 165 , 166 ]](https://figures.cochat.ai/paper-figures/7ceb67ab1aad46f89474db600a12f54d/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The transition to cellular senescence can be initiated by a loss of epigenetic information, as well as telomere shortening, irreparable DNA damage, and cytoplasmic DNA [7, 10-12].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence is a state of permanent cell cycle arrest that facilitates wound repair, tissue remodeling, and avoidance of cancer by halting proliferation in aged and damaged cells [10, 11].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, Y., Zhu, D., Chen, F., Qian, M., Wei, H., Chen, W., & Xu, J. (2016) · Oncogene · doi:10.1038/onc.2015.494 · Cited by 122
Self-citationRetractedCOVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citation
Research works printed but not linked: 6
- 10.1016/j.cell.2008.06.049 · doi:10.1016/j.cell.2008.06.049 · Paper page
- Chen C.‐L., 2018, Int. J. Mol. Sci., 38, 16
- Kang C., 2019, Mol. Cells, 42, 821
- 10.1038/onc.2015.494 · DOI
- 10.1038/s41467-019-12888-x · DOI · Paper page
- 10.18632/aging.101787 · DOI · Paper page
Cited by
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Self-citationAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Self-citationLagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276
Metadata
- Authors
- Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y.
- Affiliations
- Binzhou Medical University (CN)
- Robert and Arlene Kogod Center on Aging Mayo Clinic Rochester MN 55905 USA
- Mayo Clinic (US)
- Corresponding author
- Sun, Yu
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2020-10-19
- Volume
- 7
- Issue
- 23
- Pages
- 2002611-2002611
- ISSN
- 2198-3844 (ISSN-L)
- PMC
- PMC7709980
- OpenAlex
- W3093572772
- Cited by
- 129
- References
- 162
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 23 · 2023: 40 · 2022: 23 · 2021: 12 · 2020: 1
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Advanced Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Key Research and Development Program of China (2016YFC1302400, 2019YFC2002801)
- National Natural Science Foundation of China (81472709, 31671425, 31871380)
- Science and Technology Commission of Shanghai Municipality (20XD1404300)
- U.S. Department of Defense (PC111703)
- National Institutes of Health (R37‐AG013925, P01 AG062413)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, senolytics, senotherapy, healthy aging, age-related diseases, cell cycle arrest, senolytic therapy, precision medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities. https://app.cochat.ai/papers/10.1002/advs.202002611
- The paper
- Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y. (2020). Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities. Advanced Science. https://doi.org/10.1002/advs.202002611
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.